TRB Chemedica (UK) Ltd was established in January 2002 as the British subsidiary of a Swiss healthcare group which is a research-based company specialising in the application of non-animal hyaluronan for medical purposes.
TRB Chemedica (UK) Ltd are responsible for marketing the following rheumatology and ophthalmology products
Rheumatology
Ophthalmology
Ostenil®
Ostenil® – Viscoelastic solution for injecting into the joint cavity.
